GS
RDY icon

GTS Securities’s Dr. Reddy's Laboratories RDY Stock Holding History

GTS Securities’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-93,208
Closed -$1.31M – 1765
2025
Q4 		$1.31M Buy
+93,208
New +$1.31M 0.04% 334

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

GTS Securities's RDY Position: Q1 2026 in Review

GTS Securities sold out of Dr. Reddy's Laboratories (RDY) in Q1 2026, closing a stake of 93,208 shares — an estimated $1.31M sold.

GTS Securities first reported a position in RDY in Q4 2025 and held it in 1 quarter. The position peaked at $1.31M in Q4 2025. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • GTS Securities reported no remaining Dr. Reddy's Laboratories position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 93,208 Dr. Reddy's Laboratories shares in Q1 2026, an estimated $1.31M.
  • GTS Securities first reported a position in Dr. Reddy's Laboratories in Q4 2025 and held it in 1 quarter.
  • GTS Securities's Dr. Reddy's Laboratories position peaked at $1.31M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.